Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Sleep Apnea, ObstructiveDiabetes Mellitus
Interventions
DEVICE

Continuous positive airway pressure

CPAP at therapeutic pressure; ResMed S9 device in fixed pressure mode (Sydney, Australia).

DEVICE

Sham continuous positive airway pressure

CPAP at non-therapeutic pressure; ResMed S9 device using a ResMed sham mask (Sydney, Australia).

Trial Locations (2)

02115

Brigham & Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

Sanjay R Patel

OTHER

NCT01629862 - Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter